# Jenny Jiang

> Jenny Jiang is a Series C investor at Highlight Capital (Nanjin) backing Hospital and Health Care. See 1 investments, check sizes, portfolio. Updated Aug 2026.

- Type: Angel Investor
- Fund: [Highlight Capital](https://shizune.co/investors/profile/highlight-capital-llc)
- Location: Nanjin, China
- Total investments: 1
- Last investment: Feb 2018
- Lead investor: 100%
- Last updated: Aug 2026
- LinkedIn: https://www.linkedin.com/in/yanye-jenny-jiang-91b2471a

Jenny Jiang is a Series C investor at Highlight Capital in Nanjin focused on Hospital and Health Care. 8+ years of experience in venture investment and management consulting Prior to joining HighLight, Jenny was senior associate at Fidelity Growth Partners Asia, associate at Fountainvest Partners and analyst at McKinsey & Company Bachelor of Science in Life Science, Shanghai Jiaotong University

## Investment focus

### Industry

| Industry | Investments | Share |
| --- | --- | --- |
| Hospital | 1 | 100% |
| Health Care | 1 | 100% |
| Clinical Trials | 1 | 100% |

## Investments

| Company | Description | Amount | Stage | Date | Website |
| --- | --- | --- | --- | --- | --- |
| Junhetang | Junhetang is an operator of traditional Chinese medicine clinics. It is a chain of traditional Chinese medicine (TCM) healthcare management and service centers. Junherang has combined TCM culture, rare and renowned TCM experts, personalized medical services and convenient internet services to establish an innovative TCM service network witheducation, training, medical care, health maintenance and IT service functions. The company operates a chain of clinics that offers traditional Chinese medicines and therapies including herbal medicine, acupuncture, massage, exercise and dietary therapies.Headquartered in Nanjing, an ancient city in China, Junhetang is now expanding its business in different cities in China, such as Nanjing, Shanghai, Shenzhen, Chengdu, Taiyuan and so on. | $16M | Series C | Feb 08, 2018 |  |

1 of 1 investments shown.

## About Highlight Capital

VC Fund · Nanjin, China

Highlight Capital is an investment firm dedicated to support healthcare companies to generate robust and sustained growth prospect.

5 contacts available at Highlight Capital.

| Name | Title | Profile |
| --- | --- | --- |
| Alvin Yan | Vice President | https://shizune.co/investors/profile/alvin-yan |
| Bing Chen | Vice President | https://shizune.co/investors/profile/bing-chen-3 |
| Jenny Jiang | Executive Director | https://shizune.co/investors/profile/jenny-jiang |
| Pascal-Christian Sarana | Director | https://shizune.co/investors/profile/pascal-christian-sarana |
| Steven Wang | Founder & CEO | https://shizune.co/investors/profile/steven-wang-3 |

## Similar investors

### Similar stage
- [Sequoia Capital](https://shizune.co/investors/profile/sequoia-capital) — VC Fund
- [New Enterprise Associates](https://shizune.co/investors/profile/new-enterprise-associates) — VC Fund
- [Bessemer Venture Partners](https://shizune.co/investors/profile/bessemer-venture-partners) — VC Fund

## FAQ

### What does Jenny Jiang invest in?

Jenny Jiang invests primarily in Hospital, Health Care and Clinical Trials startups, most often at Series C stage. Most of the 1 investments tracked by Shizune back companies in China. The Investment Focus section breaks down every industry, stage and country in the portfolio.

### When did Jenny Jiang last invest?

The most recent investment recorded for Jenny Jiang closed in Feb 2018. Shizune tracks 1 investments in total for this profile, including round sizes, stages and portfolio companies, all sourced from confirmed public funding rounds and refreshed monthly.

### Is Shizune's investor data accurate?

Yes — every stat on this profile is calculated from confirmed public funding rounds monitored across hundreds of sources since 2020. This profile was last refreshed in Aug 2026 and is updated monthly. Spotted something off? Use the “Suggest an edit” link near the top of the page.

# About Shizune
Shizune.co is an investor database. Core features:
- 48,091 startup investors (angels, VCs, accelerators, and others)
- Email, phone, LinkedIn (for intros), socials, and other contact data
- Updated daily from public funding news
- CSV and Excel export

The User can access the full database FOR FREE after signing up: shizune.co